Despite being the second most prevalent neoplasm – the third among men after lung and prostate cancer, and the second among women after breast cancer –, many in Italy have […]
News in the category Featured
UniCamillus and Argentina’s Universidad del Salvador: partners of the future
On 28th December, UniCamillus Rector Gianni Profita signed a Memorandum of Understanding with his counterpart, Professor Carlos Salvadores de Arzuaga, at the Universidad del Salvador (USAL). This agreement marks the beginning […]
Spanish scientists “resurrect” millions of years old proteins to correct human albinism
Spanish scientists have published a study that recreates the enzymes Cas9, molecules that work as scissors that can cut the DNA of any living being at a specific point and […]
Recruiting Day with Gruppo Sanimedica | 13th January 2023
Job opportunities for graduates and graduating students of UniCamillus: Recruiting Day promoted by the Placement Office of the University in collaboration with Gruppo Sanimedica.
12th January 2023 – from 10 A.M. to 12 P.M.
Multiple myeloma: more than €10.000 per year for patients and healthcare
Medications, specialist visits, healthcare, holidays to take or lost working days: more than half of multiple myeloma patients give up work. And one in four family members have to give […]
Cancer – New approaches in the fight against neoplasms
In recent years, immunotherapies such as CAR T-cells have taken personalised treatment to a new level. These chimeric cells are created after extracting the patient’s T-lymphocytes (specialised cells of the […]
Rome Revision Shoulder Arthoplasty Course | 3rd – 4th February 2023
Opportunità di lavoro per i laureandi e laureati di UniCamillus, con la collaborazione di Randstad Medical. 3 novembre 2022 ore 14.00 – 17.30.
Health, data from the “prevale” 2022 regional programme presented: Lazio returns to pre-pandemic levels
Outgoing Lazio Region Health Councillor, Alessio D’Amato, presented the results of the six-monthly update of the regional programme PreVale 2022 data on treatment volumes and outcomes on Tuesday: “The volume […]
UniCamillus cover story Higher Education Review magazine
Higher Education Review magazine’s cover story of December 2022 is dedicated to UniCamillus
Alzheimer’s Drug Data Demonstrates Some Relief And Also Serious Risks
A clinical trial on 1,700 patients in various countries: Lecanemab, an experimental drug against Alzheimer’s disease, reduces cognitive decline in 27 cases per 100.
An artificial womb keeps a lamb alive for weeks
The video is a shocking one: a sheep fetus, placed inside an artificial womb, is filmed five days after premature birth. The video shows the typical activity and developmental appearance […]
Alzheimer’s, a new drug to reduce disease progression
Biogen and Eisai, two American pharmaceutical companies, have created a monochlorinated drug, which is laboratory-produced proteins that simulate the functioning of the immune system, called “Leconemab.” This drug, Leconemab, reduces […]
Loading...